Jade Biosciences
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -9 | -12 | -1 |
EBITDA | -34,900 | -25,163 | -32,133 |
EBIT | -34,909 | -25,175 | -32,134 |
Net Income | -67,583 | -25,175 | -32,134 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -33,652 | -22,181 | -36,671 |
Cash | 88,438 | 50,106 | 220,942 |
Basic Shares | 49,316 | 39,584 | 28,431 |
Annual Financials
| Values in thousands | 2025-12-31 |
|---|---|
Revenue | $0 |
Gross Profit | -26 |
EBITDA | -113,542 |
EBIT | -113,568 |
Net Income | -127,410 |
Net Change In Cash | 0 |
Free Cash Flow | -94,885 |
Cash | 88,438 |
Basic Shares | 31,359 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.48 |
2025-06-30 | -$0.86 |
2025-03-31 | -$12.10 |
2024-12-31 | -$6.61 |
